🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🌟Excited to share our latest work on how functionally distinct skin TRM utilise different pathways to establish residency, published today in Science Magazine! A true labour of love by BFF Simone Park and Susan Christo! 👩‍🔬 Doherty Institute University of Melbourne UniMelb MDHS science.org/doi/10.1126/sc…

🙌 Susan Christo explaining the implications of our research to 7NEWS Melbourne yesterday!

thank you also to Herald Sun heraldsun.com.au/lifestyle/heal… and RN Breakfast abc.net.au/listen/program… for spotlighting our work yesterday! 🌟🫶

thank you for featuring our study on the Doherty Podcast this week Doherty Institute ! was great to talk science 🤓🧬👩‍🔬 follow the link below to listen!!

congratulations Emma, Thomas and co. on a really cool study on how CD4 T cells control melanoma! excellent to see this work out in print 🙌🥳

so excited to see this story from the amazing Dr Becs and Joseph Sun Lab out this week! super cool data on how dietary restriction can modulate NK cell function and cancer immunity, massive congratulations to my 🇦🇺 sci-sister Bec! 🙌💫🍾 you are awesome!

and also excited today to see Divij paper from the lab online now in Science Magazine , a mammoth effort exploring how JAK inhibition modulates checkpoint immunotherapy responses! congratulations Divij!!! science.org/doi/10.1126/sc…

Very happy to share this new work on LAG3 and PD1. Has been a long road to (begin to) sort out how LAG3 functions in CD8 T cell exhaustion. Great work by Shin Ngiow and super collaboration (and 2 other great papers) with Vignali Lab and Dario Vignali cell.com/cell/abstract/…

1/ 🚨 Hot off the press! 🚨Our new paper, led by Andreas Obers & Maximilien Evrard, is now live in Immunity! 🧬 Curious how CD8+ tissue-resident memory T cells (TRM) adopt their fate in different organs? Let’s dive in! 🧵👇 authors.elsevier.com/c/1jw~j_OR~yiO…

Our latest study, led by Susan Christo, shows CD47 × PD-L1 bispecific antibodies enhance tumor-resident CD8+ T cell responses, boosting anti-tumor immunity. Grateful to partner with Pfizer Oncology Medical to advance cancer research! 🔬 Doherty Institute onlinelibrary.wiley.com/doi/full/10.10…

Excited to share my graduate work from the E. John Wherry lab on the molecular mechanisms locking in the differentiation fate of exhausted CD8 T cells (Tex), published earlier this month in @SciImmuno. Main findings below! science.org/doi/10.1126/sc…